CHESTERBROOK, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will host a conference call on Wednesday, March 7, 2018 at 8:00 am EST to review financial results as of and for the quarter and year ended December 31, 2017 and to discuss recent corporate highlights.
To join the call, please dial-in at (855) 465-0180 (conference ID: 7843918).
To join a live audio webcast of the call, please visit the Investor Presentation section of the Company’s website (conference ID: 7843918). Following the conclusion of the call, the webcast will be available for replay for 30 days.
Trevena, Inc. is a biopharmaceutical company focused on providing better, safer therapies to patients in pain. The Company has leveraged breakthrough science to discover and develop its investigational product OLINVO™ (oliceridine) Injection for the management of moderate-to-severe acute pain. The Company also has an early stage pipeline of new chemical entities targeting novel mechanisms of action, including for acute migraine, neuropathic pain, and other indications.
Jonathan Violin, Ph.D.
SVP, scientific affairs and investor relations officer